Zobrazeno 1 - 10
of 12
pro vyhledávání: '"Bernadetta, Ceglarek"'
Autor:
Ewa, Kalinka-Warzocha, Jaroslaw, Wajs, Ewa, Lech-Maranda, Bernadetta, Ceglarek, Jerzy, Holowiecki, Irena, Federowicz, Jan, Walewski, Jaroslaw, Czyz, Tadeusz, Robak, Krzysztof, Warzocha, Elzbieta, Kisiel
Publikováno v:
Cancer. 113:367-375
BACKGROUND. The objective of this study was to compare the efficacy of 3 regimens, cladribine alone, cladribine and cyclophosphamide combination, or cyclophosphamide, vincristine, and prednisone combination in previously untreated patients with low-g
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::73683507a1e055fa38d20c4271f3c7bf
https://doi.org/10.1002/cncr.23558
https://doi.org/10.1002/cncr.23558
Autor:
Bernadetta Ceglarek, Lech Konopka, Tadeusz Robak, Aleksander B. Skotnicki, Marek Kasznicki, Kazimierz Sulek, Krystyna Zawilska, Jadwiga Dwilewicz-Trojaczek, Beata Stella-Holowiecka, Malgorzata Calbecka, Joanna Góra-Tybor, Kazimierz Kuliczkowski, Krzysztof Warzocha, Anna Dmoszynska, Krzysztof Jamroziak, Małgorzata Kowal, Janusz Kloczko, Agnieszka Tomaszewska, Jerzy Z. Blonski
Publikováno v:
Blood. 108:473-479
In this prospective randomized trial, we compared the efficacy and toxicity of cladribine (2-CdA) alone to 2-CdA combined with cyclophosphamide (CC) or cyclophosphamide and mitoxantrone (CMC) in untreated progressive chronic lymphocytic leukemia (CLL
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::407a8e9ef77f8b84ba449ffda35a931f
https://doi.org/10.1182/blood-2005-12-4828
https://doi.org/10.1182/blood-2005-12-4828
Autor:
Bernadetta Ceglarek, Lech Konopka, Tadeusz Robak, Marek Kasznicki, Anna Dmoszynska, I Góra-Tybor, Aleksander B. Skotnicki, Wieslaw Nowak, Malgorzata Calbecka, Dariusz Wołowiec, J Sułek, P. Boguradzki, Kazimierz Kuliczkowski, Beata Stella-Holowiecka, Jadwiga Dwilewicz-Trojaczek, Jerzy Z. Blonski, B Moskwa-Sroka
Publikováno v:
Leukemia. 15:1510-1516
The objective of the study was to determine the effectiveness and the toxicity of a combined chemotherapy consisting of cladribine (2-CdA), mitoxantrone and cyclophosphamide (CMC regimen) in the treatment of previously untreated B cell chronic lympho
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9ca84d16cdd03b1fc4d8323fba722703
https://doi.org/10.1038/sj.leu.2402216
https://doi.org/10.1038/sj.leu.2402216
Autor:
Aleksander B. Skotnicki, Wieslaw Nowak, Beata Stella-Holowiecka, Malgorzata Calbecka, Krzysztof Lewandowski, Krzysztof Warzocha, Tadeusz Robak, Bernadetta Ceglarek, Janusz Kloczko, Joanna Gora-Tybor, Kazimierz Kuliczkowski, Aleksandra Kostyra, Anna Dmoszynska, Jerzy Z. Blonski, Jadwiga Dwilewicz-Trojaczek, Stanisław Potoczek, Ilona Seferynska, Andrzej Hellmann, Elżbieta Wiater, Andrzej Mital, Krzysztof Chojnowski, Jacek Treliński, Krystyna Zawilska, Kazimierz Sulek, Małgorzata Kowal
Objectives The relationship between treatments of chronic lymphocytic leukemia (CLL) with cladribine (2-CdA) or chlorambucil and immune thrombocytopenia (IT) has not been yet determined. Methods The records of 777 patients in two randomized Polish Ad
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e832e4d3aa9262ff9e29eaf86548f817
https://ruj.uj.edu.pl/xmlui/handle/item/119341
https://ruj.uj.edu.pl/xmlui/handle/item/119341
Autor:
Aneta, Kopacz, Anna, Bielecka, Maria, Mikulska, Piotr, Grabarczyk, Paulina, Zwolińska, Beata, Wojciechowska, Magdalena, Łetowska, Elzbieta, Kisiel, Krzysztof, Warzocha, Bernadetta, Ceglarek, Andrzej B, Szczepanik, Andrzej, Szczepiński, Katarzyna, Owczarska, Konrad, Pielaciński, Ewa, Brojer
Publikováno v:
Przeglad epidemiologiczny. 66(1)
The study assessed the incidence of HBV markers (HBsAg, anti-HBc, anti-HBs) important for determination of the risk of reactivation of infection, with particular interest of occult infection (presence of HBV DNA in the absence of HBsAg) in patients t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::ad30ea64e9db2d11a4c8a3aa6b716956
https://pubmed.ncbi.nlm.nih.gov/22708290
https://pubmed.ncbi.nlm.nih.gov/22708290
Autor:
Magdalena Piotrowska, Krzysztof Lewandowski, Jaroslaw Piszcz, Andrzej Zdunczyk, Krzysztof Jamroziak, Ilona Seferynska, Beata Stella-Holowiecka, Jadwiga Dwilewicz-Trojaczek, Aleksandra Kostyra, Krystyna Zawilska, Lech Konopka, Bernadetta Ceglarek, Tadeusz Robak, Andrzej Hellmann, Stanisław Potoczek, Joanna Gora-Tybor, Jerzy Z. Blonski, Anna Dmoszynska, Malgorzata Calbecka, Krzysztof Warzocha
Publikováno v:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 28(11)
Purpose Little is known about comparison of the activity of different purine nucleoside analogs in chronic lymphocytic leukemia (CLL). We conducted a randomized phase III trial to compare efficacy and safety of cladribine and fludarabine, each combin
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2edbe30366f5a20be0bd5fc36e2a5a00
https://pubmed.ncbi.nlm.nih.gov/20212251
https://pubmed.ncbi.nlm.nih.gov/20212251
Autor:
Tadeusz, Robak, Jerzy Z, Błoński, Marek, Kasznicki, Joanna, Góra-Tybor, Anna, Dmoszyńska, Maria, Wojtaszko, Aleksander B, Skotnicki, Wiesław, Nowak, Andrzej, Hellmann, Krzysztof, Lewandowski, Barbara, Zdziarska, Lech, Konopka, Bernadetta, Ceglarek, Jadwiga, Dwilewicz-Trojaczek, Piotr, Boguradzki, Kazimierz, Kuliczkowski, Kazimierz, Sułek, Krzysztof, Warzocha
Publikováno v:
Medical science monitor : international medical journal of experimental and clinical research. 11(10)
We previously published an early report of a randomized, multicenter trial on the efficacy and toxicity of cladribine (2-CdA) + prednisone (P) compared with chlorambucil (Chl) + P in previously untreated patients with progressive or symptomatic chron
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::40a52378ae4c5ab1a8501231380668aa
https://pubmed.ncbi.nlm.nih.gov/16192912
https://pubmed.ncbi.nlm.nih.gov/16192912
Autor:
Ilona Seferynska, Aleksander B. Skotnicki, Kazimierz Kuliczkowski, Bernadetta Ceglarek, Beata Stella-Holowiecka, Wieslaw Nowak, Elżbieta Wiater, Lech Konopka, Krzysztof Lewandowski, Stanisław Potoczek, Anna Dmoszynska, Jerzy Z. Blonski, Andrzej Zdunczyk, Aleksandra Kostyra, Malgorzata Calbecka, Krzysztof Chojnowski, Tadeusz Robak, Krzysztof Warzocha, Jacek Treliński, Janusz Kloczko, Jadwiga Dwilewicz-Trojaczek, Krystyna Zawilska, Andrzej Hellmann, Andrzej Mital, Małgorzata Kowal, Kazimierz Sulek
Publikováno v:
Blood. 112:4179-4179
Autoimmune disorders like immune haemolytic anemia (AIHA) and immune thrombocytopenia (IT) represent the autoimmune haematological conditions most frequently associated with chronic lymphocytic leukemia (CLL). Recently there has been several case rep
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::679e58e35f988f99a4efb7b5aa47b507
https://doi.org/10.1182/blood.v112.11.4179.4179
https://doi.org/10.1182/blood.v112.11.4179.4179
Autor:
Marzena Watek, Tadeusz Robak, Kazimierz Sulek, Bernadetta Ceglarek, Krzysztof Warzocha, Jaroslaw Wajs, W.W. Jędrzejczak, Irena Federowicz, Grzegorz Mazur, Ewa Kalinka, Piotr Centkowski, Maria Blasinska-Morawiec, Jerzy Holowiecki
Publikováno v:
ResearcherID
To comparatively assess first-line treatment with cladribine single (C) or in combination with cyclophosphamide (CC), and COP (cyclophosphamide, vincristine, prednisone) in low grade B-cell non-Hodgkin lymphoma (NHL), previously untreated patients (p
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::53a159ff57e310b7566f178eefaf4ba6
https://doi.org/10.1182/blood.v108.11.2481.2481
https://doi.org/10.1182/blood.v108.11.2481.2481
Autor:
Ilona Seferynska, Joanna Sawczuk-Chabin, Bernadetta Ceglarek, Maria Blasinska-Morawiec, Kazimierz Sulek, Lech Konopka, Jaroslaw Wajs, Piotr Centkowski, Krzysztof Warzocha, Tadeusz Robak, Ewa Kalinka
Publikováno v:
ResearcherID
The aim of the study was to comparatively assess first-line treatment with cladribine alone or in combination with cyclophosphamide (CCR, cladribine-containing regimens) and COP (cyclophosphamide, vincristine, prednisone) in different subtypes of low
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f0fd9036d5357d048cb39575727798f9
https://doi.org/10.1182/blood.v106.11.4739.4739
https://doi.org/10.1182/blood.v106.11.4739.4739